Dasgupta, P., Kulkarni, P., Bhat, N. S., Majid, S., Shiina, M., Shahryari, V., . . . Hashimoto, Y. (2020). Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer. Toxicol Appl Pharmacol.
Styl ChicagoDasgupta, Pritha, et al. "Activation of the Erk/MAPK Signaling Pathway Is a Driver for Cadmium Induced Prostate Cancer." Toxicol Appl Pharmacol 2020.
Citace podle MLADasgupta, Pritha, et al. "Activation of the Erk/MAPK Signaling Pathway Is a Driver for Cadmium Induced Prostate Cancer." Toxicol Appl Pharmacol 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..